Your browser doesn't support javascript.
loading
Serum macrophage inflammatory protein 3α levels predict the severity of HBV-related acute-on-chronic liver failure.
Xin, Jiaojiao; Ding, Wenchao; Hao, Shaorui; Chen, Xin; Zhang, Jianing; Jiang, Longyan; Zhou, Qian; Shi, Dongyan; Zhang, Liyuan; Xu, Xiaowei; Cao, Hongcui; Li, Lanjuan; Li, Jun.
Afiliação
  • Xin J; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Ding W; Systems Biology Division, Zhejiang-California International Nanosystems Institute, Zhejiang University, Hangzhou, China.
  • Hao S; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Chen X; Department of Bioinformatics, College of Life Sciences, Zhejiang University, Hangzhou, China.
  • Zhang J; Department of Bioinformatics, College of Life Sciences, Zhejiang University, Hangzhou, China.
  • Jiang L; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhou Q; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Shi D; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhang L; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Xu X; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Cao H; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Li L; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Li J; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Gut ; 65(2): 355-7, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26041751

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Quimiocina CCL20 / Insuficiência Hepática Crônica Agudizada / Hepatite B Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Gut Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Quimiocina CCL20 / Insuficiência Hepática Crônica Agudizada / Hepatite B Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Gut Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China